Ifp Advisors, Inc Bio Affinity Technologies, Inc. Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 10,000 shares of BIAF stock, worth $8,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$8,000
Previous $20,000
55.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIAF
# of Institutions
16Shares Held
527KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$208,6950.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$79,6400.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$37,0430.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$22,3080.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$14,0800.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.18M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...